Also trades as: WGS (NASDAQ) · $vol 44M
WGSWW NASDAQ
GeneDx Holdings Corp.
1W: -39.7%
1M: -34.0%
3M: -79.3%
YTD: -92.5%
1Y: -92.2%
3Y: -81.0%
5Y: -99.9%
$0.01
+0.00 (+82.86%)
Weekly Expected Move ±63.7%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.0028-0.0762
Volume6,900
Avg Volume65,518
Beta2.07
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKatherine A. Stueland
Employees1,000
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-07-23
Websitegenedx.com
North Tower
Stamford, DE 06902
US
Stamford, DE 06902
US
888 729 1206
About GeneDx Holdings Corp.
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Latest News
GeneDx Holdings Corp. Q1 2026 Earnings Call Summary
GeneDx expects $475M-$490M 2026 revenue as it targets at least 30% exome/genome volume growth
Do You Believe in GeneDx Holdings Corp.’s (WGS) Durable Competitive Moat?
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Increases By 75.2%
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of “Moderate Buy” from Analysts
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Casdin Capital, LLC | P-Purchase | 50,000 | — | 2026-05-11 |
| Casdin Capital, LLC | P-Purchase | 300,000 | — | 2026-05-08 |
| Casdin Capital, LLC | P-Purchase | 500,000 | — | 2026-05-07 |
| Stueland Katherine | M-Exempt | 3,874 | — | 2026-04-29 |
| Stueland Katherine | M-Exempt | 3,874 | — | 2026-04-29 |